Schedule 13D ownership disclosure

Lexicon Pharmaceuticals Inc

Security class unavailable · CUSIP: 528872302

Event date: 2022-08-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
20.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-216196
Form type
SC 13D/A
Filer
Invus, L.P.
CIK
CIK 1404570
Filed
Aug 09, 2022
Reporting period
Aug 05, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub